BREAKING NEWS
  • GOOG828.64-2.69 -0.32%
  • EGFDF0.05+0.00 +0.00%
  • AAPL136.66+0.13 +0.10%
  • WFC57.81-0.68 -1.16%
  • IBM181.35-0.30 -0.17%
  • MCD128.65+0.38 +0.30%
  • X37.01-0.30 -0.80%
  • AA34.48+0.16 +0.47%
  • DXJ50.90-0.53 -1.03%
  • FXI38.54-0.42 -1.08%
  • FCX13.25-0.23 -1.71%
  • MON112.96+0.63 +0.56%
  • DE108.62+0.89 +0.83%
  • KO41.78+0.12 +0.29%
  • JNJ122.73+1.83 +1.51%
  • NVS77.28-0.17 -0.22%
  • HAL52.87-0.32 -0.60%
  • SLB80.15-0.32 -0.40%
  • GE30.19+0.17 +0.57%
  • MRK66.16+0.31 +0.47%
  • PCLN1631.62-5.64 -0.34%
  • FB135.44+0.08 +0.06%
  • POT17.87-0.20 -1.11%
  • WP Stock Ticker

Why 1st Constitution Bancorp (FCCY) Stock Might be a Great Pick

One stock that might be an intriguing choice for investors right now is 1st Constitution Bancorp FCCY This is because this security in the Banks Northeast space is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry Rank perspective This...
Posted On 24 Feb 2017

Looking for Value? Why It Might Be Time to Try PulteGroup (PHM)

Value investing is always a very popular strategy and for good reason After all who doesn t want to find stocks that have low PEs solid outlooks and decent dividends Fortunately for investors looking for this combination we have identified a strong candidate which may be an Source
Posted On 24 Feb 2017

Why You Shouldnt Bet Against MKS Instruments (MKSI) Stock

One stock that might be an intriguing choice for investors right now is MKS Instruments Inc MKSI This is because this security in the Electronics Manufacturing Machinery space is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry Source
Posted On 24 Feb 2017

Should You Get Rid of Dun Bradstreet Corp. (DNB) Now?

Similar to wise buying decisions exiting certain underperformers at the right time helps maximize portfolio returns Selling off losers can be difficult but if both the share price and estimates are falling it could be time to get rid of the security before more losses hit your...
Posted On 24 Feb 2017

Do Options Traders Know Something About YPF S.A. (YPF) Stock We Dont?

Investors in YPF S A YPF need to pay close attention to the stock based on moves in the options market lately That is because the February 24 th 2017 18 Put had some of the highest implied volatility of all equity options today What is Implied Volatility Implied volatility Source
Posted On 24 Feb 2017

Should You Sell Comstock Resources (CRK) Before Earnings?

Investors are always looking for stocks that are poised to beat at earnings season and Comstock Resources Inc CRK may be one such company The firm has earnings coming up pretty soon and events are shaping up quite nicely for their report That is because Comstock Resourcesis...
Posted On 24 Feb 2017

Aeglea Biotherapeutics (AGLE) Looks Good: Stock Jumps 7%

Aeglea Biotherapeutics Inc AGLE was a big mover last session as the company saw its shares rise over 7 on the day The move came on solid volume with far more shares changing hands than in a normal session This breaks the recent trend of the company as the stock is now trading...
Posted On 24 Feb 2017

Should You Buy Calumet Specialty Products (CLMT) Ahead of Earnings?

Investors are always looking for stocks that are poised to beat at earnings season and Calumet Specialty Products Partners L P CLMT may be one such company The firm has earnings coming up pretty soon and events are shaping up quite nicely for their report That is because Calumet Source
Posted On 24 Feb 2017

BHP Billiton (BHP): An Off-the-Radar Potential Winner

It commonly happens in stock investing that investors miss the chance of buying winning stocks that they knew would stand out Before they take the plunge others get to know the hidden potential and enter into these stocks pushing them out of reach So instead of repenting spotting...
Posted On 24 Feb 2017

Intercept (ICPT) Reports a Wider Q4 Loss

New York based Intercept Pharmaceuticals Inc ICPT focused on bringing novel therapeutics to treat chronic liver diseases to market Intercept received a major boost with the FDA approval in May 2016 of its lead drug Ocaliva in combination with ursodeoxycholic UDCA for the Source
Posted On 24 Feb 2017